784 related articles for article (PubMed ID: 28647765)
21. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
Kee KM; Lu SN
Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
[TBL] [Abstract][Full Text] [Related]
22. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
23. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
25. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres.
Cazzagon N; Trevisani F; Maddalo G; Giacomin A; Vanin V; Pozzan C; Poggio PD; Rapaccini G; Nolfo AM; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Foschi FG; Cabibbo G; Felder M; Ciccarese F; Missale G; Baroni GS; Morisco F; Pecorelli A; Farinati F;
Liver Int; 2013 Oct; 33(9):1420-7. PubMed ID: 23758775
[TBL] [Abstract][Full Text] [Related]
26. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
[TBL] [Abstract][Full Text] [Related]
27. Surveillance for hepatocellular carcinoma: how can we do better?
Hassett M; Yopp AC; Singal AG
Am J Med Sci; 2013 Oct; 346(4):308-13. PubMed ID: 23426089
[TBL] [Abstract][Full Text] [Related]
28. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
29. Hepatocellular carcinoma. A worldwide problem and the major risk factors.
Simonetti RG; Cammà C; Fiorello F; Politi F; D'Amico G; Pagliaro L
Dig Dis Sci; 1991 Jul; 36(7):962-72. PubMed ID: 1649041
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma: diagnostics and screening.
Patel M; Shariff MI; Ladep NG; Thillainayagam AV; Thomas HC; Khan SA; Taylor-Robinson SD
J Eval Clin Pract; 2012 Apr; 18(2):335-42. PubMed ID: 21114800
[TBL] [Abstract][Full Text] [Related]
31. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
32. Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
Sayiner M; Golabi P; Younossi ZM
Dig Dis Sci; 2019 Apr; 64(4):910-917. PubMed ID: 30835028
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma epidemiology.
Bosetti C; Turati F; La Vecchia C
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):753-70. PubMed ID: 25260306
[TBL] [Abstract][Full Text] [Related]
34. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
Goldberg DS; Taddei TH; Serper M; Mehta R; Dieperink E; Aytaman A; Baytarian M; Fox R; Hunt K; Pedrosa M; Pocha C; Valderrama A; Kaplan DE
Hepatology; 2017 Mar; 65(3):864-874. PubMed ID: 27531119
[TBL] [Abstract][Full Text] [Related]
35. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
[TBL] [Abstract][Full Text] [Related]
36. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
37. Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.
Zakharia K; Luther CA; Alsabbak H; Roberts LR
S Afr Med J; 2018 Aug; 108(8b):35-40. PubMed ID: 30182911
[TBL] [Abstract][Full Text] [Related]
38. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
Larcos G; Sorokopud H; Berry G; Farrell GC
AJR Am J Roentgenol; 1998 Aug; 171(2):433-5. PubMed ID: 9694470
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma and hepatitis C in the United States.
El-Serag HB
Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579
[TBL] [Abstract][Full Text] [Related]
40. Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Wong LL; Reyes RJ; Kwee SA; Hernandez BY; Kalathil SC; Tsai NC
Clin Mol Hepatol; 2017 Sep; 23(3):239-248. PubMed ID: 28706177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]